Bioactive compounds: safety and efficacy
2009
Biesalski, H. K. | Dragsted, L. O. | Elmadfa, I. | Grossklaus, R. | Muller, M. | Schrenk, D. | Walter, P. | Weber, P.
Alemán. The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart
Mostrar más [+] Menos [-]Palabras clave de AGROVOC
Información bibliográfica
Editorial Nutrition
ISSN 0899-9007Este registro bibliográfico ha sido proporcionado por German Federal Institute for Risk Assessment